Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-31 @ 8:54 PM
Study NCT ID:
NCT04900935
Status:
RECRUITING
Last Update Posted:
2025-11-24
First Post:
2021-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Patient-centered, Optimal Integration of Survivorship and Palliative Care
Sponsor:
Massachusetts General Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Stage IV Non-small Cell Lung Cancer | View |
| None | Targeted Therapy | View |
| None | Nonsmall Cell Lung Cancer | View |
| None | Carcinoma, Non-Small-Cell Lung | View |
| None | ALK-positive Non-small Cell Lung Cancer | View |
| None | EGFR Positive Non-small Cell Lung Cancer | View |
| None | Palliative Care | View |
| None | Survivorship | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Stage IV Non-small Cell Lung Cancer | View |
| None | Targeted Therapy | View |
| None | Nonsmall Cell Lung Cancer | View |
| None | Carcinoma, Non-Small-Cell Lung | View |
| None | ALK-positive Non-small Cell Lung Cancer | View |
| None | EGFR Positive Non-small Cell Lung Cancer | View |
| None | ROS1 Positive Non-Small Cell Lung Cancer | View |
| None | Palliative care | View |
| None | survivorship | View |
| None | RET Fusion positive Non-Small Cell Lung Cancer | View |